Tobin Juvenal
Corporate Officer/Principal chez CASTLE BIOSCIENCES, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Tobin W.
Juvenal is currently the Chief Commercial Officer at Castle Biosciences, Inc. He previously worked as the Director & Manager-District Sales at AstraZeneca LP, Vice President-Sales at Encysive Pharmaceuticals, Inc., Manager-Area Sales at deCODE genetics, Inc., and Vice President-Sales at Genzyme Pharmaceuticals, Inc. Mr. Juvenal completed his undergraduate degree at the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0,18% | 04/03/2024 | 49 087 ( 0,18% ) | 1 M $ | 31/03/2024 |
Postes actifs de Tobin Juvenal
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/08/2020 |
Anciens postes connus de Tobin Juvenal
| Sociétés | Poste | Fin |
|---|---|---|
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Sales & Marketing | 01/01/2007 |
Genzyme Pharmaceuticals, Inc.
 Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Sales & Marketing | - |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Director/Board Member | - |
deCODE genetics, Inc.
 deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Sales & Marketing | - |
Formation de Tobin Juvenal
| University of Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CASTLE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
deCODE genetics, Inc.
deCODE genetics, Inc. Pharmaceuticals: GenericHealth Technology deCODE genetics, Inc. is a bio-pharmaceutical company. It developing and marketing products to improve the treatment, diagnosis and prevention of common diseases. deCODE applies its capabilities in chemistry and structural biology to the development of drugs in major therapeutic areas, and applies its discoveries in human genetics to bring to market DNA-based reference laboratory tests and consumer genome analysis services to assess individual risk of common diseases. The company was founded by Kari Stefansson and Jeffrey Gulcher in August 1996 and is headquartered in Reykjavík, Iceland. | Health Technology |
Genzyme Pharmaceuticals, Inc.
Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The private company is based in Wilmington, DE. | Health Technology |
